50 天前 - … of S309-CAR-NK immunotherapy as an alternative treatment for COVID-19 patients.
… -based immunotherapy has not been seriously explored in treating COVID-19 patients with …

53 天前 - … The rapid clinical development and potential for swift, economical manufacturing
have propelled mRNA vaccines to the forefrontin combating the COVID-19 pandemic. However…

56 天前 - … With recent developments and clinical translation of mRNA lipid nanoparticle (LNP)
therapeutics (as in COVID-19 vaccines), there has been a significant focus on mRNA as an …

60 天前 - … [ 34 ] Therefore, when we screen targeted drugs, we focus on proven
immunotherapy-related drugs, which also improves the possibility of transformation to some extent. …

60 天前 - … (IT) injections of the COVID-19 mRNA vaccine on the … a single IT injection of the
COVID-19 mRNA-1273 vaccine … vaccines may be used as adjuvants for immunotherapies. …

60 天前 - … COVID-19 infection. After shared decision making with the patient, a booster dose
of mRNA-1273 COVID-19 … allergen immunotherapy, or influenza and COVID-19 vaccine, …

61 天前 - … In turn, microbes modulate disease immunotherapy. … immunotherapy, particularly
immune checkpoint inhibitors (ICIs). In addition, the most critical issue now is a COVID-19 …

61 天前 - … of pwMS during the Coronavirus disease 2019 (COVID-19) pandemic and the effect
of … that immunotherapy may potentially act as a protective factor against worse COVID-19 …

61 天前 - … of the Austrian COVID-19 immunisation campaign were … chemo- or immunotherapy
experienced significantly more … prevent severity and mortality of COVID-19 in MM patients. […

61 天前 - … The success of mRNA vaccines against COVID-19 has enhanced the potential of
lipid … Recent progress in NK cell targeting in cancer immunotherapy is also introduced. Finally, …